Óscar Fernández - Concepedia

Author

Óscar Fernández

Hospital Regional Universitario de Málaga ORCID

Also Known As

Fernández, Oscar, Guillermo Izquierdo, Guillermo Izquierdo Ayuso, Instituto Federal do Pará (IFPA), Belém, Pará, Brasil, M. D. Fernández, María Dolores Fernández-Pérez, Michel Clanet, O FERNANDEZ, O Fernandez, O Fernández

358

Publications

8.5K

Citations

H-Index

128

Concepts

All Affiliations

Hospital Regional Universitario de Málaga Hospital Universitario Virgen Macarena Instituto de Investigación Biomédica de Málaga Instituto de Parasitología y Biomedicina "López - Neyra"Consejo Superior de Investigaciones Científicas

ÓF

About

Óscar Fernández is an author at Hospital Regional Universitario de Málaga specializing in medicine, multiple sclerosis, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	48	3.4K
2	Public Health	9	9	525
3	Health Sciences	3	4	282
4	Natural Sciences	1	1	51
5	Social Sciences	1	1	43

Óscar Fernández

126

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study Giancarlo Comi, Massimo Filippi, Frederik Barkhof, The Lancet Autoimmune DiseaseNeurological DisorderImmunologyClinical TrialsClinical Neurology	2001	1.1K
Validation of the Multiple Sclerosis International Quality of Life questionnaire M.C. Simeoni, Pascal Auquier, Óscar Fernández, Multiple Sclerosis Journal	2007	190
Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial O. R. Hommes, Per Soelberg Sørensen, Franz Fazekas, The Lancet Autoimmune DiseaseIntravenous ImmunoglobulinImmunodeficienciesMedicineImmunology	2004	183
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial Diego Cadavid, Michelle Mellion, Raymond Hupperts, The Lancet Neurology Neurological DisorderClinical NeurologyClinical TrialsNeurological ProgressNeurology	2019	173
Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis Esther Byun, Stacy J. Caillier, Xavier Montalbán, Archives of Neurology	2008	170
Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study Óscar Fernández, Guillermo Izquierdo, Victoria Fernández, PLoS ONE	2018	154
Multiple Sclerosis Risk Variant HLA-DRB1*1501 Associates with High Expression of DRB1 Gene in Different Human Populations Antonio Alcina, María M. Abad‐Grau, Marı́a Fedetz, PLoS ONE GeneticsGenetic EpidemiologyImmunologyPathologyHuman Polymorphism	2012	152
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial Tomas Olsson, Aaron Boster, Óscar Fernández, Journal of Neurology Neurosurgery & Psychiatry	2014	147
Interferon regulatory factor 5 (<i>IRF5</i>) gene variants are associated with multiple sclerosis in three distinct populations Guðrún Kristjánsdóttir, Johanna K. Sandling, Alessandro Bonetti, Journal of Medical Genetics	2008	146
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a Frederik Barkhof, Gordon Francis, Jan‐Hein T. M. van Waesberghe, Annals of Neurology	2003	135

Page 1